INTERNATIONAL BUSINESS TIMES
NEWSLETTER SIGNUP
login my account
  • My account
  • Log Out
Oct 22, 1:59 PM EDT
  • U.S.
  • World
  • Politics
  • Economy & Markets
  • Business
  • Crypto
  • Technology
  • Opinion
  • Deals & Reviews
NEWSLETTER
login my account
  • My account
  • Log Out
  • U.S.
  • World
  • Politics
  • Economy & Markets
  • Business
  • Crypto
  • Technology
  • Opinion
  • Deals & Reviews
Listings & More
  • Spotlight
  • Glossary
  • SMB Forum
  • CEO Spotlight
Editions
  • Australia Edition
  • Korea Edition
  • Japan Edition
  • India Edition
  • Singapore Edition
  • United Kingdom
  • United States
NEWSLETTER
Follow Us
Editions
  • Australia Edition
  • Korea Edition
  • Japan Edition
  • India Edition
  • Singapore Edition
  • United Kingdom
  • United States
Glossary
Glossary > Small Medium Business
Categories
  • Small Medium Business
  • #
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • XYZ
K
  • Key Success Factors
  • Knocked Down (KD)
Go back to Main List
  • MOST READ
  • 1
    Paris
    Protests Keep Escalating in France. The Government Will Now Deploy the Military.
  • 2
    Abbas Araghchi
    Trump Has Promised to 'Finish The Job' in Iran. Tehran Answered With a Taunt of its Own.
  • 3
    Bank
    AI Agents Are Accessing U.S. Bank Accounts Without Their Approval. Lenders Are Pushing Back.
  • 4
    Musk
    Elon Musk Wants To Give Every American Child A SpaceX Share. The Giveaway Could Be Worth Over $10 Billion.
  • 5
    stocks
    The S&P 500 Is Up More Than 10% This Year: But Nearly 40% of S&P 500 Stocks Are Down 20% From Their Highs.
TERM OF THE DAY
Sign Up Now

Abbreviated New Drug Submission

A request for approval from Health Canada for a generic drug. Allowing manufacturing and marketing to move forward, it essentially submits efficacy and safety data for review.
Read more

NEWS
  • World
  • U.S.
  • Economy & Markets
  • Business
  • Technology
  • Politics
  • Crypto
  • Opinion
Featured
  • Visionary Voices
  • Social Capital
  • SMB Forum
  • Spotlight
  • Press Release
  • CEO Spotlight
  • Deals & Reviews
ABOUT
  • About us
  • Contact us
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • Advertise with us
Editions
  • Australia
  • India
  • Singapore
  • United Kingdom
  • United States
FOLLOW US
  • Facebook
  • Twitter
  • LinkedIn
  • Flipboard
  • Instagram
  • Newsletter
IBTimes
© Copyright 2026 IBT Media Inc. All Rights Reserved.